Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Blood Clot

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Blood Clot in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morrell, CN1
Sun, H1
Ikeda, M1
Beique, JC1
Swaim, AM1
Mason, E1
Martin, TV1
Thompson, LE1
Gozen, O1
Ampagoomian, D1
Sprengel, R1
Rothstein, J1
Faraday, N1
Huganir, R1
Lowenstein, CJ1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Blood Clot

ArticleYear
Glutamate mediates platelet activation through the AMPA receptor.
    The Journal of experimental medicine, 2008, Mar-17, Volume: 205, Issue:3

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anim

2008